Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
or

Cassava Sciences Inc (SAVA)

Cassava Sciences Inc (SAVA)
1.2500 x 5 1.2700 x 2
Post-market by (Cboe BZX)
1.2700 +0.0800 (+6.72%) 04/11/25 [NASDAQ]
1.2500 x 5 1.2700 x 2
Post-market 1.2500 -0.0200 (-1.57%) 19:45 ET
Quote Overview for Fri, Apr 11th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
1.2100
Day High
1.2900
Open 1.2200
Previous Close 1.1900 1.1900
Volume 887,700 887,700
Avg Vol 2,225,170 2,225,170
Stochastic %K 5.66% 5.66%
Weighted Alpha -76.16 -76.16
5-Day Change -0.0300 (-2.31%) -0.0300 (-2.31%)
52-Week Range 1.1500 - 42.2000 1.1500 - 42.2000
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 61,351
  • Shares Outstanding, K 48,308
  • Annual Sales, $ 0 K
  • Annual Income, $ -24,340 K
  • EBIT $ -141 M
  • EBITDA $ -140 M
  • 60-Month Beta -1.48
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.39

Options Overview Details

View History
  • Implied Volatility 131.14% ( -157.84%)
  • Historical Volatility 132.40%
  • IV Percentile 61%
  • IV Rank 9.19%
  • IV High 753.77% on 04/09/25
  • IV Low 68.09% on 01/16/25
  • Put/Call Vol Ratio 0.11
  • Today's Volume 1,252
  • Volume Avg (30-Day) 3,230
  • Put/Call OI Ratio 0.14
  • Today's Open Interest 105,013
  • Open Int (30-Day) 112,766

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Sell
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1.41
  • Growth Rate Est. (year over year) +70,951.06%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1500 +10.43%
on 04/10/25
Period Open: 2.5800
3.0500 -58.36%
on 03/18/25
-1.3100 (-50.78%)
since 03/11/25
3-Month
1.1500 +10.43%
on 04/10/25
Period Open: 2.8300
3.0500 -58.36%
on 03/18/25
-1.5600 (-55.12%)
since 01/10/25
52-Week
1.1500 +10.43%
on 04/10/25
Period Open: 26.1100
42.2000 -96.99%
on 08/05/24
-24.8400 (-95.14%)
since 04/11/24

Most Recent Stories

More News
Cassava Sciences Stock Drops Over 30% After Alzheimer’s Drug Fails Study – But Retail Remains Hopeful

The drug showed no treatment benefit for patients in the study called REFOCUS-ALZ, the company said, while adding that the Alzheimer’s disease development program with Simufilam will be discontinued...

VTI : 261.74 (+1.67%)
IWM : 184.36 (+1.46%)
SAVA : 1.2700 (+6.72%)
Cassava Sciences Reports Topline Phase 3 REFOCUS-ALZ Data

SAVA : 1.2700 (+6.72%)
Cassava Sciences Reports 2024 Financial Results and Provides Business Update

SAVA : 1.2700 (+6.72%)
Cassava Sciences Licenses Simufilam Method of Treatment Patent

SAVA : 1.2700 (+6.72%)
Cassava Sciences Provides a Business Update

SAVA : 1.2700 (+6.72%)
Contact Levi & Korsinsky by February 10, 2025 Deadline to Join Class Action Against Cassava Sciences, Inc. (SAVA)

New York, New York--(Newsfile Corp. - January 2, 2025) - Levi & Korsinsky, LLP notifies investors in Cassava Sciences, Inc. ("Cassava Sciences, Inc." or the "Company") (NASDAQ: SAVA) of a class action...

SAVA : 1.2700 (+6.72%)
Anavex Sciences Soars On Earnings Relief, EU Filing Acceptance For Alzheimer’s Drug: Retail’s Overjoyed

The broader market’s interest in Alzheimer’s therapies remains intense, particularly after Cassava Sciences reported disappointing results for its candidate simufilam last month.

AVXL : 8.86 (+3.75%)
SAVA : 1.2700 (+6.72%)
News Movers: Your Daily Digest of Stocks That Released News Which Moved the Market

SURG : 2.25 (-3.43%)
PSTX : 9.50 (-0.63%)
KULR : 1.2200 (+0.83%)
TOYO : 2.80 (+1.82%)
AVXL : 8.86 (+3.75%)
MAXN : 3.10 (-5.49%)
POET : 3.73 (+1.63%)
SAVA : 1.2700 (+6.72%)
News Movers: Your Daily Digest of Stocks That Released News Which Moved the Market

WealthyVC.com scans North America’s 10,000+ publicly listed stocks across all seven exchanges to find the market-moving news that matters. Our focus is on quality, liquid, growth-oriented companies in...

SURG : 2.25 (-3.43%)
KULR : 1.2200 (+0.83%)
PSTX : 9.50 (-0.63%)
AVXL : 8.86 (+3.75%)
TOYO : 2.80 (+1.82%)
MAXN : 3.10 (-5.49%)
PTK.VN : 5.190 (+1.76%)
POET : 3.73 (+1.63%)
SAVA : 1.2700 (+6.72%)
A Post-Mortem on Cassava Sciences

There are few things in the investment world scarier than owning a biotech that misses the mark. That was the case this morning with once high-flying stock Cassava Sciences (SAVA). This is a stock that...

SAVA : 1.2700 (+6.72%)

Business Summary

Cassava Sciences Inc. is focused on the early detection and treatment of neurodegenerative diseases, such as Alzheimer's. Cassava Sciences Inc., formerly known as Pain Therapeutics Inc., is based in Austin, United States.

See More

Key Turning Points

3rd Resistance Point 1.3833
2nd Resistance Point 1.3367
1st Resistance Point 1.3033
Last Price 1.2700
1st Support Level 1.2233
2nd Support Level 1.1767
3rd Support Level 1.1433

See More

52-Week High 42.2000
Fibonacci 61.8% 26.5189
Fibonacci 50% 21.6750
Fibonacci 38.2% 16.8311
Last Price 1.2700
52-Week Low 1.1500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar